Personalized Medicine

Papers
(The H4-Index of Personalized Medicine is 9. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Application of Transcriptomics and Proteomics in Pulmonary Arterial Hypertension72
The Pharmacogenetics of Mycophenolate Mofetil in Tunisian Renal Transplant Patients28
Developing the Workplace Learning Social System: considerations for genomics implementation and workforce preparedness17
Microsatellite Instability Testing in Colorectal Patients with Lynch Syndrome: Lessons Learned from a Case Report and How to Avoid Such Pitfalls17
Genetic Predisposition for the Development of Lamotrigine-Induced Stevens–Johnson Syndrome/Toxic Epidermal Necrolysis: a Systematic Review and Meta-Analysis15
A scoping review of the cost-effectiveness of precision treatment in chronic lymphocytic leukemia15
Predictive value of miR-132-3p for the onset of sepsis-induced acute kidney injury and its functional role during disease development13
Perceived understanding and psychosocial outcomes: employees’ responses to learning results of workplace genetic testing12
Pharmacogenomics education in China and the United States: advancing personalized medicine10
miR-559 rs58450758 polymorphism is associated with colorectal cancer risk and prognosis in Chinese Han population9
1.3532040119171